| Capecitabine Accord |
Human |
capecitabine |
capecitabine |
EMEA/H/C/002386 |
Accord Healthcare S.L.U. |
2012/04/20
|
Authorised |
| Nimenrix |
Human |
meningococcal groups A, C, W-135 and Y conjugate vaccine |
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid |
EMEA/H/C/002226 |
Pfizer Europe MA EEIG |
2012/04/20
|
Authorised |
| Sancuso |
Human |
granisetron |
granisetron |
EMEA/H/C/002296 |
Grünenthal GmbH |
2012/04/20
|
Authorised |
| Zoledronic acid Actavis |
Human |
zoledronic acid |
zoledronic acid monohydrate |
EMEA/H/C/002488 |
Actavis Group PTC ehf |
2012/04/20
|
Authorised |
| Bronchitol |
Human |
mannitol |
mannitol |
EMEA/H/C/001252 |
Pharmaxis Europe Limited |
2012/04/13
|
Authorised |
| Sabervel |
Human |
irbesartan |
irbesartan |
EMEA/H/C/002510 |
Pharmathen S.A. |
2012/04/13
|
Expired |
| Pioglitazone Teva |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002297 |
Teva B.V. |
2012/03/26
|
Withdrawn |
| Pioglitazone Teva Pharma |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002410 |
Teva Pharma B.V. |
2012/03/26
|
Withdrawn |
| Pioglitazone Accord |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002277 |
Accord Healthcare S.L.U. |
2012/03/21
|
Authorised |
| Paglitaz |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002309 |
Krka, d.d., Novo mesto |
2012/03/21
|
Lapsed |
| Pioglitazone Krka |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002453 |
Krka, d.d., Novo mesto |
2012/03/21
|
Withdrawn |
| Pioglitazone Actavis |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002324 |
Actavis Group PTC ehf |
2012/03/15
|
Authorised |
| Glidipion (previously Pioglitazone Actavis Group) |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002558 |
Actavis Group PTC ehf |
2012/03/15
|
Withdrawn |
| Xaluprine (previously Mercaptopurine Nova Laboratories) |
Human |
mercaptopurine |
6-mercaptopurine monohydrate |
EMEA/H/C/002022 |
Lipomed GmbH |
2012/03/09
|
Authorised |
| Sepioglin |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/002021 |
Vaia S.A. |
2012/03/09
|
Withdrawn |
| RevitaCAM |
Veterinary |
meloxicam |
meloxicam |
EMEA/V/C/002379 |
Zoetis Belgium SA |
2012/02/23
|
Withdrawn |
| Esmya |
Human |
ulipristal |
ulipristal acetate |
EMEA/H/C/002041 |
Gedeon Richter Ltd |
2012/02/22
|
Withdrawn |
| Zelboraf |
Human |
vemurafenib |
vemurafenib |
EMEA/H/C/002409 |
Roche Registration GmbH |
2012/02/17
|
Authorised |
| Vepacel |
Human |
prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture) |
Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1) |
EMEA/H/C/002089 |
Ology Bioservices Ireland LTD |
2012/02/17
|
Withdrawn |
| Caprelsa |
Human |
vandetanib |
vandetanib |
EMEA/H/C/002315 |
Sanofi B.V. |
2012/02/16
|
Authorised |